White matter changes associated with antipsychotic treatment in first-episode psychosis

Neuropsychopharmacology

Volumn 39, Issue 6, 2014, Pages 1324-1331

  Szeszko, Philip R ^a,b,c   Robinson, Delbert G ^a,b,c   Ikuta, Toshikazu ^d   Peters, Bart D ^a,b   Gallego, Juan A ^a,b,c   Kane, John ^a,b,c   Malhotra, Anil K ^a,b,c  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b Division of Psychiatry Research Zucker Hillside Hospital North Shore LIJ Health System ^*  (United States)

^c DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^d UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

antipsychotic; diffusion tensor imaging; first episode psychosis; white matter

Indexed keywords

ARIPIPRAZOLE; LOW DENSITY LIPOPROTEIN; RISPERIDONE; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; MALE; METABOLIC DISORDER; OCCIPITAL CORTEX; PARIETAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; TREATMENT RESPONSE; WHITE MATTER; ANISOTROPY; BLOOD; BRAIN; DRUG EFFECTS; FOLLOW UP; LONGITUDINAL STUDY; MYELINATED NERVE; OCCIPITAL LOBE; PARIETAL LOBE; PATHOLOGY; PSYCHOTIC DISORDERS; YOUNG ADULT;

ANISOTROPY; ANTIPSYCHOTIC AGENTS; BRAIN; DIFFUSION TENSOR IMAGING; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPOPROTEINS, LDL; LONGITUDINAL STUDIES; MALE; NERVE FIBERS, MYELINATED; OCCIPITAL LOBE; PARIETAL LOBE; PIPERAZINES; PSYCHOTIC DISORDERS; QUINOLONES; RISPERIDONE; YOUNG ADULT;

EID: 84900835578     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.288     Document Type: Article

References (52)

1. Bartzokis G, Lu PH, Amar CP, Raven EP, Detore NR, Altshuler LL et al (2011). Long acting injection vs oral risperidone in firstepisode schizophrenia: differential impact on white matter myelination trajectory. Schizophr Res 132: 35-41.
2. Bartzokis G, Lu PH, Nuechterlein KH, Gitlin M, Doi C, Edwards N et al (2007). Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophr Res 93: 13-22. (Pubitemid 46830753)
3. Bartzokis G, Lu PH, Stewart SB, Oluwadara B, Lucas AJ, Pantages J et al (2009). In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia. Schizophr Res 113: 322-331.
4. Behrens TE, Berg HJ, Jbabdi S, Rushworth MF, Woolrich MW (2007). Probabilistic diffusion tractography with multiple fibre orientations: What can we gain? Neuroimage 34: 144-155. (Pubitemid 44765263)
5. Björkhem I, Meaney S (2004). Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 24: 806-815. (Pubitemid 38620856)
6. Blank T, Prinz M (2013). Microglia as modulators of cognition and neuropsychiatric disorders. Glia 61: 62-70.
7. Bushe C, Paton C (2005). The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link? J Psychopharmacol 19: 76-83. (Pubitemid 44567861)
8. Chandran P, Upadhyay J, Markosyan S, Lisowski A, Buck W, Chin CL et al (2012). Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice. Neuroscience 202: 446-453.
9. Crisby M, Bronge L, Wahlund LO (2010). Low levels of high density lipoprotein increase the severity of cerebral white matter changes: implications for prevention and treatment of cerebrovascular diseases. Curr Alzheimer Res 7: 534-539.
10. De Hert M, Detraux J, van Winkel R, Yu W, Correll CU (2011). Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 8: 114-126.
11. Dietschy JM, Turley SD (2001). Cholesterol metabolism in the brain. Curr Opin Lipidol 12: 105-112. (Pubitemid 32242918)
12. Dietschy JM, Turley SD (2004). Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45: 1375-1397. (Pubitemid 39022664)
13. Dorph-Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA (2005). The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30: 1649-1661. (Pubitemid 43086022)
14. Ferno J, Raeder MB, Vik-Mo AO, Skrede S, Glambek M, Tronstad KJ et al (2005). Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action? Pharmacogenomics J 5: 298-304. (Pubitemid 41486229)
15. Friedman JI, Tang C, Carpenter D, Buchsbaum M, Schmeidler J, Flanagan L et al (2008). Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. Am J Psychiatry 165: 1024-1032.
16. Girgis RR, Diwadkar VA, Nutche JJ, Sweeney JA, Keshavan MS, Hardan AY (2006). Risperidone in first-episode psychosis: a longitudinal, exploratory voxel-based morphometric study. Schizophr Res 82: 89-94. (Pubitemid 43202651)
17. Gons RA, van Norden AG, de Laat KF, van Oudheusden LJ, van Uden IW, Zwiers MP et al (2011). Cigarette smoking is associated with reduced microstructural integrity of cerebral white matter. Brain 134: 2116-2124.
18. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V (2011). Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 68: 128-137.
19. Hoffmann VP, Case M, Stauffer VL, Jacobson JG, Conley RR (2010). Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controlled clinical trials. J Clin Psychopharmacol 30: 656-660.
20. Huang TL, Chen JF (2005). Serum lipid profiles and schizophrenia: effects of conventional or atypical antipsychotic drugs in Taiwan. Schizophr Res 80: 55-59.
21. Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM (2012). FSL. NeuroImage 62: 782-790.
22. Jones DK, Catani M, Pierpaoli C, Reeves SJ, Shergill SS, O'Sullivan M et al (2005). A diffusion tensor magnetic resonance imaging study of frontal cortex connections in very-late-onset schizophrenia-like psychosis. Am J Geriatr Psychiatry 13: 1092-1099 PubMed PMID: 16319302. (Pubitemid 46638654)
23. Karlsson HK, Tuulari JJ, Hirvonen J, Lepomäki V, Parkkola R, Hiltunen J et al (2013). Obesity is associated with white matter atrophy: A combined diffusion tensor imaging and voxel-based morphometric study. Obesity (Silver Spring) 21: 2530-2537.
24. Kimoto S, Okuda A, Toritsuka M, Yamauchi T, Makinodan M, Okuda H et al (2011). Olanzapine stimulates proliferation but inhibits differentiation in rat oligodendrocyte precursor cell cultures. Prog Neuropsychopharmacol Biol Psychiatry 35: 1950-1956.
25. Kodl CT, Franc DT, Rao JP, Anderson FS, Thomas W, Mueller BA et al (2008). Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes 57: 3083-3089.
26. Konopaske GT, Dorph-Petersen KA, Sweet RA, Pierri JN, Zhang W, Sampson AR et al (2008). Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry 63: 759-765. (Pubitemid 351400762)
27. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS et al (2005). Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 62: 361-370. (Pubitemid 40471685)
28. Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A (1999). Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry 56: 367-374. (Pubitemid 29165183)
29. Molina V, Reig S, Sanz J, Palomo T, Benito C, Sanchez J et al (2005). Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia. Schizophr Res 80: 61-71. (Pubitemid 41587464)
30. Overall JE, Gorham DR (1962). The brief psychiatric rating scale. Psychol Rep 10: 799-812.
31. Palaniyappan L, Al-Radaideh A, Mougin O, Gowland P, Liddle PF (2013). Combined white matter imaging suggests myelination defects in visual processing regions in schizophrenia. Neuropsychopharmacology 38: 1808-1815.
32. Paul RH, Grieve SM, Niaura R, David SP, Laidlaw DH, Cohen R et al (2008). Chronic cigarette smoking and the microstructural integrity of white matter in healthy adults: a diffusion tensor imaging study. Nicotine Tob Res 10: 137-147.
33. Robinson DG, Woerner MG, Napolitano B, Patel RC, Sevy SM, Gunduz-Bruce H et al (2006). Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes. Am J Psychiatry 163: 2096-2102. (Pubitemid 46114229)
34. Saher G, Brügger B, Lappe-Siefke C, Möbius W, Tozawa R, Wehr MC et al (2005). High cholesterol level is essential for myelin membrane growth. Nat Neurosci 8: 468-475. (Pubitemid 41007564)
35. Shimoji K, Abe O, Uka T, Yasmin H, Kamagata K, Asahi K et al (2013). White matter alteration in metabolic syndrome: diffusion tensor analysis. Diabetes Care 36: 696-700.
36. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE et al (2006). Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31: 1487-1505.
37. Smith SM, Nichols TE (2009). Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44: 83-98.
38. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH (2003). Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 20: 1714-1722. (Pubitemid 37468277)
39. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH (2002). Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17: 1429-1436. (Pubitemid 35333862)
40. Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, Cross AH et al (2005). Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 26: 132-140. (Pubitemid 40602893)
41. Stanek KM, Grieve SM, Brickman AM, Korgaonkar MS, Paul RH, Cohen RA et al (2011). Obesity is associated with reduced white matter integrity in otherwise healthy adults. Obesity (Silver Spring) 19: 500-504.
42. Szeszko PR, Narr KL, Phillips OR, McCormack J, Sevy S, Gunduz-Bruce H et al (2012). Magnetic resonance imaging predictors of treatment response in first episode schizophrenia. Schizophr Bull 38: 569-578.
43. Szeszko PR, Ardekani BA, Ashtari M, Kumra S, Robinson DG, Sevy S et al (2005). White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. Am J Psychiatry 162: 602-605. (Pubitemid 40343930)
44. Szeszko PR, Robinson DG, Ashtari M, Vogel J, Betensky J, Sevy S et al (2008). Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia. Neuropsychopharmacology 33: 976-984. (Pubitemid 351367538)
45. Vik-Mo AO, Ferno J, Skrede S, Steen VM (2009). Psychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells. BMC Pharmacol 9: 10.
46. Voineskos AN, Lobaugh NJ, Bouix S, Rajji TK, Miranda D, Kennedy JL et al (2010). Diffusion tensor tractography findings in schizophrenia acrosss the adult lifespan. Brain 133: 1494-1504.
47. Walterfang M, Velakoulis D, Whitford TJ, Pantelis C (2011). Understanding aberrant white matter development in schizophrenia: an avenue for therapy? Expert Rev Neurother 11: 971-987.
48. Wang Q, Cheung C, Deng W, Li M, Huang C, Ma X et al (2013). White-matter microstructure in previously drug naive patients with schizophrenia after 6 weeks of treatment. Psychol Med 43: 1-9.
49. Williams VJ, Leritz EC, Shepel J, McGlinchey RE, Milberg WP, Rudolph JL et al (2012). Interindividual variation in serum cholesterol is associated with regional white matter tissue integrity in older adults. Hum Brain Mapp 34: 1826-1841.
50. Xiao L, Xu H, Zhang Y, Wei Z, He J, Jiang W et al (2008). Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Mol Psychiatry 13: 697-708. (Pubitemid 351861531)
51. Xu J, Li Y, Lin H, Sinha R, Potenza MN (2013). Body mass index correlates negatively with white matter integrity in the fornix and corpus callosum: a diffusion tensor imaging study. Hum Brain Mapp 34: 1044-1052.
52. Zhang Y, Zhang H, Wang L, Jiang W, Xu H, Xiao L et al (2012). Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination. Schizophr Res 138: 8-17.